Prince Pharmaceutical Co (ROCO:6935) Other Current Payables: NT$73 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6935 Prince Pharmaceutical Co Ltd ROCO:6935
56 GF Score
Price NT$29.60
GF Value NT$42.23
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Prince Pharmaceutical Co Other Current Payables?

Prince Pharmaceutical Co ROCO:6935 +4.59% 56 Other Current Payables is NT$73 Mil as of Dec. 2025. GuruFocus rates ROCO:6935 with a GF Score™ of 56/100 and a GF Value™ of NT$42.23 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Prince Pharmaceutical Co's Other Current Payables for the quarter that ended in Dec. 2025 was NT$73 Mil.

Prince Pharmaceutical Co's quarterly Other Current Payables declined from Dec. 2024 (NT$50 Mil) to Jun. 2025 (NT$48 Mil) but then increased from Jun. 2025 (NT$48 Mil) to Dec. 2025 (NT$73 Mil).

Prince Pharmaceutical Co's annual Other Current Payables declined from Dec. 2023 (NT$53 Mil) to Dec. 2024 (NT$50 Mil) but then increased from Dec. 2024 (NT$50 Mil) to Dec. 2025 (NT$73 Mil).

Prince Pharmaceutical Co Other Current Payables Related Terms

Prince Pharmaceutical Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for Prince Pharmaceutical Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prince Pharmaceutical Co Other Current Payables Chart

Prince Pharmaceutical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial 36.03 50.86 52.76 50.19 73.04

Prince Pharmaceutical Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.76 53.00 50.19 48.11 73.04
ROCO:6935
56GF Score
Prince Pharmaceutical Co Ltd ROCO:6935
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prince Pharmaceutical Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of NT$73 Mil mean?
Prince Pharmaceutical Co (ROCO:6935) has a Other Current Payables of NT$73 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Prince Pharmaceutical Co and its competitors.
Is Prince Pharmaceutical Co's Other Current Payables too high?
Prince Pharmaceutical Co's current Other Current Payables is NT$73 Mil. Overall, Prince Pharmaceutical Co has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Prince Pharmaceutical Co's Other Current Payables compare to ZTS and UTHR?
Prince Pharmaceutical Co's Other Current Payables of NT$73 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Prince Pharmaceutical Co and its competitors. Prince Pharmaceutical Co's current Other Current Payables is NT$73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prince Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Prince Pharmaceutical Co (ROCO:6935) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$42.23, compared to a current price of NT$29.60 — trading 29.9% below its estimated fair value. The current Other Current Payables is NT$73 Mil. Prince Pharmaceutical Co's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Prince Pharmaceutical Co (ROCO:6935), the current Other Current Payables is NT$73 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prince Pharmaceutical Co (ROCO:6935) Overvalued in 2026?

Based on GuruFocus' analysis, Prince Pharmaceutical Co stock appears to be undervalued. The current stock price of NT$29.60 is trading 29.9% below its estimated GF Value™ of NT$42.23. GuruFocus considers Prince Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for ROCO:6935:

  • Other Current Payables: NT$73 Mil
  • GF Value™: NT$42.23 vs. price of NT$29.60 (29.9% below fair value)
  • GF Score™: 56/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6935 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Prince Pharmaceutical Co Business Description

Address Number 168, Keyunnan Road, Huwei Town, Yunlin, TWN, 632
Prince Pharmaceutical Co Ltd is engaged in the manufacturing, packaging, processing, and trading of various active pharmaceutical ingredients and health supplements. The company supplies its products to Taiwan, Japan, Spain, Europe and other regions.
56GF Score

Get the complete analysis for ROCO:6935

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$29.60
Price
NT$42.23
GF Value